| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 8,029 | 11,090 | 4,993 | 2,826 | | Cost of Revenue |
-
| (6,100) | 6,100 |
-
| | | Gross Profit | 8,029 | 17,191 | (1,107) | 2,826 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 5,588 | 11,271 | (1,539) | 5,245 | | Non Recurring | 1,242 |
-
|
-
|
-
| | Others | 63 | 56 | 67 | 74 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 2,378 | 5,863 | 365 | (2,493) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| (4,617) |
-
|
-
| | Earnings Before Interest And Taxes | 2,378 | 1,247 | 365 | (2,493) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 2,378 | 1,247 | 365 | (2,493) | | Income Tax Expense | 981 | 284 | 37 | (810) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,397 | 963 | 328 | (1,683) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,397 | 963 | 328 | (1,683) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,397 | $963 | $328 | ($1,683) |
|
0.01% Nasdaq 
Income Statement
